Challenges of patient recruitment for invasive aspergillosis trials

Area of Science:

• Medical Mycology
• Clinical Trial Design
• Infectious Diseases

Background:

• Invasive aspergillosis (IA) patient recruitment faces significant hurdles in clinical trials.
• Low incidence and stringent inclusion criteria limit the number of eligible patients.
• Current recruitment rates (2-18 patients/month) are insufficient for large-scale studies.

Purpose of the Study:

• To analyze challenges in patient recruitment for invasive aspergillosis trials.
• To identify factors contributing to low patient enrollment rates.
• To propose strategies for improving recruitment and trial efficiency.

Main Methods:

• Analysis of patient recruitment data from recent first-line and salvage therapy IA trials.
• Review of common difficulties encountered in IA trial recruitment.
• Examination of diagnostic and endpoint selection in IA studies.

Main Results:

• Recruitment rates in IA trials are consistently low, ranging from 2 to 18 patients per month.
• Disease rarity, restrictive inclusion criteria, and competing trials impede enrollment.
• Non-inferiority trial designs often require hundreds of patients, exacerbating recruitment challenges.

Conclusions:

• Improving early diagnosis through novel methods is crucial to increase the number of treatable patients.
• Exploring alternative study endpoints can shorten trial duration and reduce patient numbers.
• Strategic adjustments in trial design and diagnostics are necessary to overcome recruitment barriers in IA research.